# Organon & Co. (OGN): MoatMap facts

As of 14 Oct 2026. Research data, not investment advice.

As of 14 Oct 2026, MoatMap's StockRank for Organon & Co. (OGN) is 95/100, ranked against 24,000+ stocks in 35 markets (Quality 57, Value 70, Momentum 75, each scored against its sector).

- StockRank: 95/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 57, Value 70, Momentum 75: each a 0-100 percentile within the stock's sector.
- Position: #1,254 overall, #138 in Healthcare.
- Listing: United States, NYQ; Healthcare / Drug Manufacturers - General.
- Last close: 13.77 USD on 12 Oct 2026.
- Insider filings, last 180 days: directors sold USD 200K.

Source: https://moatmap.ai/stock/OGN
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker